Brendan Smith - Aug 16, 2022 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Role
Chief Financial Officer
Signature
/s/ Elizabeth Ryland Waldinger, attorney-in-fact
Stock symbol
CRSP
Transactions as of
Aug 16, 2022
Transactions value $
$0
Form type
4
Date filed
8/18/2022, 05:39 PM
Previous filing
Feb 22, 2022
Next filing
Oct 12, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRSP Restricted Stock Units Award $0 +10K $0.00 10K Aug 16, 2022 Common Shares 10K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
F2 The restricted stock units shall vest in full on February 16, 2025, subject to continued service to the Company or any of its subsidiaries.

Remarks:

Exhibit 24 - Power of Attorney